NEWS DETAIL

Avis/Décision concernant le Programme de recherche pédiatrique (PIP) : Jyseleca, maléate de figoratinib, Type de décision : PM : Décision concernant les modifications apportées à une demande PIP approuvée, Domaine thérapeutique : Maladies musculo-squelettiques et du tissu conjonctif, Numéro PIP : EMA/PE/0000232302

Alfasigma S.p.A.

Informations médicales July 2, 2026

Contenu integral de l article

Related medicine information Alfasigma S. p. A. E-mail: medicalinfo@alfasigma. comTel: 00800 7878 1345 English (EN) (255.89 KB – PDF) EMA/PE/0000232302: EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for filgotinib maleate (Jyseleca)

Sản phẩm liên quan đến bài viết

Các sản phẩm này được tự động đối chiếu từ tiêu đề, tóm tắt và nội dung bài viết.

Câu hỏi thường gặp

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Filgotinib – Mua trực tuyến.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.